Product Information
GS NICOTINE 4 MG LOZENGE is a generic product labeled by L. Perrigo Company, priced at $0.3443 per EA under NDC 00113087305. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 31, 2006.
Strength
4 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113087305
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA077007FDA Approved
1/31/2006
On Market Since
12/27/2006
Pharmacological Classes
Price Statistics
The NADAC for GS NICOTINE 4 MG LOZENGE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3443 per EA |
|---|---|
| All-time high | $0.4244 (Oct 11, 2017) |
| All-time low | $0.3069 (Apr 17, 2024) |
| 52-week high | $0.3443 |
| 52-week low | $0.3269 |
| Median price | $0.3549 |
| Average price | $0.3544 |
| Largest weekly change | +17.9% (Sep 20, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS NICOTINE 4 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for GS NICOTINE 4 MG LOZENGE, manufactured by L. Perrigo Company, is $0.3443 per EA (NDC 00113087305), effective Sep 30, 2026.
How has the price of GS NICOTINE 4 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for GS NICOTINE 4 MG LOZENGE has declined 2.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GS NICOTINE 4 MG LOZENGE?
Since Nov 28, 2013, the NADAC for GS NICOTINE 4 MG LOZENGE has ranged from a low of $0.3069 (Apr 17, 2024) to a high of $0.4244 (Oct 11, 2017), with a median of $0.3549 per EA.
Are there cheaper alternatives to GS NICOTINE 4 MG LOZENGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS NICOTINE 4 MG LOZENGE in a comparable dosage form, but none are currently priced below it.
Who manufactures GS NICOTINE 4 MG LOZENGE?
GS NICOTINE 4 MG LOZENGE (NDC 00113087305) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.